Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus. - Wikidata - awgldk - TriplyDB

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

http://www.wikidata.org/entity/Q37056852

about

Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7).Efficacy of Rebamipide in Organic and Functional Dyspepsia: A Systematic Review and Meta-Analysis.

P2860

Q42338280-F2493D13-1CC5-4D91-A262-0321B8B146EA Q42338282-D555EFF8-EF4D-4626-9C46-F03523542E3B Q47388012-3082232C-8E61-420C-8053-E38AD820B058

P2860

Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

http://www.wikidata.org/entity/Q37056852

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 April 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@en

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@nl

type

label

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@en

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@nl

prefLabel

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@en

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@nl

P1433

Q37056852-7086C261-8608-4A57-80B1-F83EAC6AE80A

P1476

Q37056852-5712FAA9-5D80-4BE9-BE9F-3757CC306BD3

P2093

Q37056852-0855076A-1CD3-4A24-BF5B-7254555040A2

Q37056852-094F71EB-DE62-4F4F-9EBC-309212C78859

Q37056852-2BD294E8-FB4A-44F0-95AC-43E2F64E382B

Q37056852-3F8FB487-EC7E-4AB5-9C19-82847153D105

Q37056852-7079D1ED-224A-4E53-8417-07BB20FC7B47

Q37056852-8506E1F4-54D4-4F29-BD6D-A63C9893A009

Q37056852-BB780021-4607-4B6A-94B6-6C85B2712EFE

Q37056852-D3AD49A9-9F06-4A75-A947-F546A0805588

Q37056852-F72EE948-93FE-4CB0-A430-2017B1C1B226

P2860

Q37056852-0B54E990-50E5-42D2-84EC-9CC41B010977

Q37056852-1369F251-C64B-45F3-8B7B-9BD7FE200753

Q37056852-2AA35383-5EE9-4920-B478-4EB1E96AA041

Q37056852-42FBD391-5007-4894-8150-23E1959628EA

Q37056852-49E74962-9A57-485B-B6A4-CA9CE198A01A

Q37056852-4A342C0E-6A10-4817-B026-1B8A9437DFED

Q37056852-4E900D9B-1C9C-48C1-AFC6-7C162702BEA0

Q37056852-5FDD0DDB-6AA6-41A8-9F14-1CF70676ABED

Q37056852-60161E2D-E676-4C37-BB46-B5D15311F3CC

Q37056852-6C415CD3-AF18-405A-BA91-2D4366260EF2

P304

Q37056852-4B101CE8-E2D6-4A4B-978E-3C74B3415CDA

P31

Q37056852-F4E24360-2E86-45EC-A34A-0FF9CD0AF973

P356

Q37056852-CA396E5A-F5B5-4001-A82F-30D610309D59

P433

Q37056852-AC4FAFA5-4833-4894-8667-E8962D5A7DDF

P478

Q37056852-0AAEACD0-2818-4821-AD84-E7DEE3CE7575

P50

Q37056852-5F1FC61F-CC34-417A-9BF2-CB3F20990083

P577

Q37056852-8AA09099-EA0B-47F4-BC2B-5BDC7D8A099A

P698

Q37056852-AC992DB9-B5B4-4865-B891-782D159576D8

P921

Q37056852-3B89F98C-661F-4A0A-84E1-F9B95BFC027C

P932

Q37056852-CAE87A73-587F-4189-8DD9-52C33B6CB818

P356

DMJ.2016.40.3.240

P1433

Diabetes & metabolism journal

P1476

Effects of Rebamipide on Gastr ...... with Type 2 Diabetes Mellitus.

@en

P2093

Jeong Taek Woo

http://www.w3.org/2001/XMLSchema#string

Sejeong Park

http://www.w3.org/2001/XMLSchema#string

Seungjoon Oh

http://www.w3.org/2001/XMLSchema#string

So Young Park

http://www.w3.org/2001/XMLSchema#string

Soo Min Hong

http://www.w3.org/2001/XMLSchema#string

Suk Chon

http://www.w3.org/2001/XMLSchema#string

Sung Woon Kim

http://www.w3.org/2001/XMLSchema#string

Young Seol Kim

http://www.w3.org/2001/XMLSchema#string

Yu Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study

The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin.

Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life.

Relationships of upper gastrointestinal motor and sensory function with glycemic control.

Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults.

Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.

Treatment of patients with diabetic gastroparesis.

Oral erythromycin and the risk of sudden death from cardiac causes.

Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.

Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years.

P304

240-247

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4093/DMJ.2016.40.3.240

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27098506

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4929228

http://www.w3.org/2001/XMLSchema#string